Prostate Imaging – PSMA

Posted on: 31 October 2015Clinical

Cyclotek licences 18F-DCFPyL for Australia and New Zealand

Cyclotek has signed an agreement with Johns Hopkins University, for the exclusive Australian and New Zealand rights to the PSMA PET tracer DCFPyL. This novel tracer is labelled with Fluorine-18, and can be readily distributed from centralised manufacturing sites just like FDG. Cyclotek operates four cyclotron facilities, with a capacity to supply imaging sites throughout Australia and New Zealand. DCFPyL will be manufactured under GMP, alongside a number of other PET tracers for oncology and neurodegenerative diseases, which are currently available from Cyclotek.

[contact-form-7 id=”714″ title=”Update Form”]